Which testing step ensures that anti-D reagent is functioning properly and rules out false positives due to other factors?

Which testing step ensures that anti-D reagent is functioning properly and rules out false positives due to other factors?

• A. Rh control
• B. Donor screening
• C. ABO grouping
• D. DAT

Answer: (A)

The main idea is using a control to verify that a reagent is working and to catch non-specific factors that could mimic a true result. An Rh control tests the anti-D reagent with known Rh‑D positive cells to confirm the reagent is active and the testing procedure is functioning. When the Rh control shows the expected positive reaction, you can trust that a result obtained in a patient sample reflects true anti‑D activity rather than a reagent failure or technique issue. If the Rh control fails, it signals a problem with the reagent or the process, making all results suspect. This control also helps flag non-specific influences—such as autoantibodies or other factors—that could otherwise cause misleading reactions, because such issues would be revealed by an improper control. The other steps target different purposes (ABO grouping for blood type, DAT for in vivo coating, donor screening for infectious risk) and do not specifically confirm the anti-D reagent’s performance.

The main idea is using a control to verify that a reagent is working and to catch non-specific factors that could mimic a true result. An Rh control tests the anti-D reagent with known Rh‑D positive cells to confirm the reagent is active and the testing procedure is functioning. When the Rh control shows the expected positive reaction, you can trust that a result obtained in a patient sample reflects true anti‑D activity rather than a reagent failure or technique issue. If the Rh control fails, it signals a problem with the reagent or the process, making all results suspect. This control also helps flag non-specific influences—such as autoantibodies or other factors—that could otherwise cause misleading reactions, because such issues would be revealed by an improper control. The other steps target different purposes (ABO grouping for blood type, DAT for in vivo coating, donor screening for infectious risk) and do not specifically confirm the anti-D reagent’s performance.